Risankizumab Is Effective for the Management of Crohn's Disease of the Pouch

被引：0
|
作者：
Shahin, Tala B. [1 ]
Khan, Nowsherwan [1 ]
Malik, Talha A. [1 ]
机构：
[1] Mayo Clin Arizona, Dept Med Gastroenterol, Phoenix, AZ 85054 USA
来源：
INFLAMMATORY BOWEL DISEASES | 2024年 / 31卷 / 01期
关键词：
D O I：
10.1093/ibd/izae241
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：311 / 311
页数：1
相关论文
共 50 条
  • [1] Risankizumab Is Effective for The Management of Crohn's Disease of the Pouch
    Kayal, Maia
    Spencer, Elizabeth A.
    Smyth, Matthew
    Raffals, Laura
    Qazi, Taha
    Deepak, Parakkal
    Beniwal-Patel, Poonam
    Chang, Shannon
    Higgins, Peter
    Cross, Raymond K.
    Anderson, Chelsea
    Long, Millie
    Herfarth, Hans H.
    Dubinsky, Marla C.
    Barnes, Edward L.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [2] RISANKIZUMAB IS EFFECTIVE FOR THE MANAGEMENT OF CROHN'S DISEASE LIKE POUCH INFLAMMATION
    Kayal, Maia
    Smyth, Matthew
    Huang, Justin
    Jimenez, Darwin
    Helmus, Drew
    Dubinsky, Marla C.
    Spencer, Elizabeth A.
    GASTROENTEROLOGY, 2024, 166 (05) : S1142 - S1143
  • [3] Risankizumab Is Effective for the Management of Crohn's Disease of the Pouch (Jul, izae164, 2024)
    Shahin, Tala B.
    Kundi, Muhammad-Nowsherwan
    Malik, Talha A.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [4] Efficacy and Safety of Risankizumab in the Treatment of Crohn's Disease of the Pouch
    Lan, Nan
    Shen, Bo
    ACG CASE REPORTS JOURNAL, 2024, 11 (09)
  • [5] Risankizumab for Crohn's disease
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (08): : 612 - 613
  • [6] Risankizumab for Crohn's disease
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (04): : 268 - 268
  • [7] Risankizumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (08): : 709 - 709
  • [8] Risankizumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (07): : 475 - 475
  • [9] Risankizumab for Crohn's disease
    Hibi, Toshifumi
    LANCET, 2022, 399 (10340): : 1992 - 1993
  • [10] Risankizumab for Crohn's disease
    Thomas, Hugh
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (12): : 1076 - 1076
12345